Cite
HARVARD Citation
Zhou, H. et al. (2020). A randomized Phase I pharmacokinetic trial comparing the potential biosimilar trastuzumab (SIBP-01) with the reference product (Herceptin®) in healthy Chinese male volunteers. Expert opinion on drug metabolism and toxicology. pp. 997-1003. [Online].